[1]
Z. Ziad, “Factors implicated in underutilization and poor persistence with hypomethylating agent therapy in myelodysplastic syndromes and chronic myelomonocytic leukaemia in Pakistan”, J Pak Med Assoc, vol. 76, no. 07, pp. 1061–1068, Jun. 2026.